Veana Therapeutics, Inc.
New Filing
CIK: 0001741217·Biotechnology·DELAWARE·Filed: May 21, 2018
Total Offering
$2,000,000
Amount Sold
$542,000
Investors
9
First Sale
May 11, 2018
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2015
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Emmanuel Akporiaye | Related Person |
| Mark F Holifer | Related Person |
| Rebecca Akporiaye | Related Person |
| F Andrew Ray | Related Person |
| Trent D. Davis | Related Person |
| Denis R Burger | Related Person |
| Andrew D Thaler | Related Person |
| Thomas E McChesney | Related Person |
Company
SEC Filing
0001741217-18-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free